Vanderbilt Ingram Cancer Center
-
VICC’s Balko named a Susan G. Komen ‘Pink Tie Guy’
Justin Balko, Pharm.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been named a member of the 2016 class of Pink Tie Guys by the Greater Nashville Affiliate of Susan G. Komen, a nonprofit organization dedicated to breast cancer research and patient support. Read MoreDec 10, 2015
-
‘Messages of Hope’ prostate cancer event is Dec. 11
"Messages of Hope: Advances in Prostate Cancer Prevention, Research and Treatment," a free program for prostate cancer survivors, caregivers and health professionals, will be held Friday, Dec. 11, from 9 to 11 a.m. at the Vanderbilt-Ingram Cancer Center. Read MoreNov 24, 2015
-
Levy named to new VICC informatics leadership role
Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center (VICC), has been named director of Cancer Health Information and Strategy, a new management post that will expand her leadership role. Read MoreNov 19, 2015
-
VICC’s Horn lands Team Leadership Award from NCI
Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has received a 2015 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute (NCI). Read MoreNov 19, 2015
-
Five candidates sought for Runyon Cancer Clinical Investigator Award
Vanderbilt University may nominate five candidates for the 2016 Damon Runyon Cancer Research Foundation Clinical Investigator Award. Read MoreNov 13, 2015
-
Ayers Institute spurred key cancer research gains
In 2005, Tennessee philanthropists Jim and Janet Ayers gave $10 million to help Vanderbilt University scientists find early markers for colorectal cancer that could improve diagnosis and potentially save lives. Read MoreNov 12, 2015
-
Cancer Survivors Day
Cancer survivors, family and friends rock to tunes performed by Soul Incision during the annual cancer Survivors Day celebration. Read MoreNov 5, 2015
-
Investigators find clues to melanoma treatment resistance
Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway. Read MoreOct 29, 2015
-
VUMC and Incyte Corp. form new scientific alliance
Vanderbilt University Medical Center investigators have joined forces with scientists at Incyte Corp. to explore new therapies for the treatment of various types of cancer, as well as other diseases. The company has agreed to help fund basic and translational science research by VUMC investigators. Read MoreOct 22, 2015
-
Cancer Survivorship Celebration set for Nov. 1
Vanderbilt-Ingram Cancer Center, in partnership with Monroe Carell Jr. Children’s Hospital at Vanderbilt, is hosting the 2015 Cancer Survivorship Celebration Sunday, Nov. 1, from 2 to 4 p.m. at the Vanderbilt Student Life Center. Read MoreOct 22, 2015
-
New faculty: Lisa Kachnic is pioneering advances in radiation therapy
New Department of Radiation Oncology Chair Lisa Kachnic wants to make Vanderbilt's program one of the best in the country. Read MoreOct 22, 2015
-
Fundraiser for head and neck cancer patients slated for Oct. 16
The second annual Courage Unmasked event to raise awareness about head and neck cancer will be held Friday, Oct. 16, 6 – 9 p.m., at the Sarratt Gallery at Vanderbilt. Read MoreOct 8, 2015
-
Celebrate Cancer Survivors Day Nov. 1
Vanderbilt Cancer Survivors Day is Nov. 1 and features musical guest Soul Incision. Read MoreOct 8, 2015
-
Komen, VICC partnership bolsters breast cancer research
For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support. Read MoreOct 8, 2015
-
Potential target for lung cancer therapy
The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies. Read MoreOct 5, 2015
-
VICC investigators land Komen breast cancer grants
Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. Read MoreOct 1, 2015
-
Strong scores put VICC among top NCI centers
Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). Read MoreSep 17, 2015
-
New creative writing course geared for cancer community
Cancer patients, family members and those who care for cancer patients often need a way to express the deep and often lasting emotions that a cancer diagnosis can bring. Read MoreSep 3, 2015
-
Hach shows age not always a barrier to cancer therapy
Phila Hach recently celebrated her 89th birthday and she has had much to celebrate over the years. Read MoreSep 3, 2015
-
VICC offers creative writing course for cancer caregivers
Health care professionals who care for cancer patients can experience strong emotions with limited opportunities to cope with or express those emotions. During September, Vanderbilt-Ingram Cancer Center and its partners are offering a series of free writing seminars for those health care professionals. Read MoreSep 2, 2015